Anti-cancer drug ONC201 may have clinical potential for some blood cancers

Anti-cancer drug ONC201 may have clinical potential for some blood cancers

ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML), according to a recent clinical study. A research team …

(Visited 2 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.